Revvity - Public Comps and Valuation Multiples

Revvity Overview

About Revvity

Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity’s products and services are sold worldwide, with major markets in the US, Europe, and China.

Founded

1947

HQ

Employees

11K+

Website

revvity.com

Sectors

Laboratory Services
Medical Imaging & Diagnostics
Health Data & Analytics
BioTech
HealthTech

Financials

LTM Revenue $2.8B

LTM EBITDA $851M

EV

$13.2B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Revvity Financials

As of September 2025, Revvity reported last 12-month revenue of $2.8B and EBITDA of $851M.

In the same period, Revvity generated $1.7B in LTM gross profit and $576M in net income.

See Revvity valuation multiples based on analyst estimates

Revvity P&L

In the most recent fiscal year, Revvity reported revenue of $2.8B and EBITDA of $840M.

Revvity expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Revvity valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$2.8B	XXX	$2.8B	XXX	XXX	XXX
Gross Profit	$1.7B	XXX	$1.5B	XXX	XXX	XXX
Gross Margin	60%	XXX	56%	XXX	XXX	XXX
EBITDA	$851M	XXX	$840M	XXX	XXX	XXX
EBITDA Margin	30%	XXX	30%	XXX	XXX	XXX
EBIT	$775M	XXX	$347M	XXX	XXX	XXX
EBIT Margin	27%	XXX	13%	XXX	XXX	XXX
Net Profit	$576M	XXX	$270M	XXX	XXX	XXX
Net Margin	20%	XXX	10%	XXX	XXX	XXX
Net Debt	XXX	XXX	$2.0B	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Revvity including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $2.8B. EBITDA for the last twelve months was $851M. In the most recent fiscal year, Revvity achieved $2.8B in revenue and $840M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$2.8B	Analyst estimates available to subscribers	$2.8B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$1.7B	Analyst estimates available to subscribers	$1.5B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	59.6% gross margin	Analyst estimates available to subscribers	55.8% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$851M	Analyst estimates available to subscribers	$840M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	30.1% EBITDA margin	Analyst estimates available to subscribers	30.5% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$775M	Analyst estimates available to subscribers	$347M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	27.4% EBIT margin	Analyst estimates available to subscribers	12.6% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$576M	Analyst estimates available to subscribers	$270M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	20.3% net profit margin	Analyst estimates available to subscribers	9.8% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$2.0B	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Revvity

This financial data table provides comprehensive performance metrics for Revvity, a company based in United States of America. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Revvity generated $2.8B in revenue over the last twelve months.
The company achieved $851M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $1.7B.
Net income over the last twelve months reached $576M.

Fiscal Year Performance

In the most recent fiscal year, Revvity reported $2.8B in total revenue.
Fiscal year EBITDA was $840M.
The company maintained a gross profit margin of 55.8% in the most recent fiscal year.
EBITDA margin for the fiscal year was 30.5%.
Net profit margin reached 9.8% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Revvity. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Revvity Stock Performance

Revvity has current market cap of $10.8B, and EV of $13.2B.

Market Cap Evolution

Revvity Stock Data

As of October 17, 2025, Revvity's stock price is $93.

See Revvity trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$13.2B	$10.8B	XXX	XXX	XXX	XXX	$4.87

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Revvity Valuation Multiples

Revvity's trades at 4.8x EV/Revenue multiple, and 15.7x EV/EBITDA.

See valuation multiples for Revvity and 15K+ public comps

Revvity Financial Valuation Multiples

As of October 17, 2025, Revvity has market cap of $10.8B and EV of $13.2B.

Equity research analysts estimate Revvity's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Revvity has a P/E ratio of 18.8x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$10.8B	XXX	$10.8B	XXX	XXX	XXX
EV (current)	$13.2B	XXX	$13.2B	XXX	XXX	XXX
EV/Revenue	4.7x	XXX	4.8x	XXX	XXX	XXX
EV/EBITDA	15.6x	XXX	15.7x	XXX	XXX	XXX
EV/EBIT	17.1x	XXX	38.1x	XXX	XXX	XXX
EV/Gross Profit	7.8x	XXX	n/a	XXX	XXX	XXX
P/E	18.8x	XXX	40.1x	XXX	XXX	XXX
EV/FCF	24.5x	XXX	24.4x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Revvity Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Revvity Margins & Growth Rates

Revvity's last 12 month revenue growth is 3%

Revvity's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Revvity's rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Revvity's rule of X is 38% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Revvity and other 15K+ public comps

Revvity Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	3%	XXX	3%	XXX	XXX	XXX
EBITDA Margin	30%	XXX	30%	XXX	XXX	XXX
EBITDA Growth	5%	XXX	9%	XXX	XXX	XXX
Rule of 40	29%	XXX	34%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	38%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.3M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	7%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	43%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial